Question 1

Has Mark Smith received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $534,700 in general payments to Mark Smith across 154 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Mark Smith did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Mark Smith come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Jazz Pharmaceuticals Inc.	153	$533,401
Teladoc Health, Inc.	1	$1,298

Drug	Claims	Cost to plans & patients
TriumeqAbacavir/Dolutegravir/Lamivudi	13	$46,445
Invega SustennaPaliperidone Palmitate	13	$30,223
SuboxoneBuprenorphine Hcl/Naloxone Hcl	11	$13,271
Clindamycin Phosphate	15	$322
Doxycycline Hyclate	13	$174
Ondansetron OdtOndansetron	13	$162
Acyclovir	12	$36

Mark Smith

Payments from drug & device makers

Who reported the general payments

How this compares

Most prescribed under Part D

Other internal medicine in San Francisco